Burlington-based Laboratory Corp. of America's plan to purchase Covance Inc. for $6.1 billion has passed through a 30-day period of review by federal regulators with no objections, setting the stage for shareholders to vote on the deal in the near future. The deal was put before the Federal Trade Commission for review, with regulators assessing its impact on consumers and competition, through a Hart-Scott-Rodino filing.